Encompass Health (EHC) Financials

$102.30 -0.96 (-0.93%)

Closing price 03:59 PM Eastern

Extended Trading

$102.34 +0.04 (+0.04%)

As of 05:22 PM Eastern

Annual Income Statements for Encompass Health

This table shows Encompass Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	182	248	271	375	359	284	412	271	352	456
Consolidated Net Income / (Loss)	183	248	271	292	446	369	517	366	463	597
Net Income / (Loss) Continuing Operations	254	318	351	374	446	278	403	351	475	599
Total Pre-Tax Income	396	482	496	493	562	353	505	451	607	750
Total Operating Income	547	649	649	630	693	528	659	630	732	865
Total Gross Profit	1,445	1,657	1,759	1,923	1,950	1,601	1,829	1,901	2,145	2,415
Total Revenue	3,163	3,643	3,914	4,277	4,605	3,566	4,015	4,349	4,801	5,373
Operating Revenue	3,163	3,643	3,914	4,277	4,605	3,566	4,015	4,349	4,801	5,373
Total Cost of Revenue	1,718	1,986	2,155	2,354	2,655	1,965	2,186	2,448	2,656	2,958
Operating Cost of Revenue	1,671	1,986	2,155	2,354	2,655	1,965	2,186	2,448	2,656	2,958
Total Operating Expenses	898	1,008	1,110	1,294	1,257	1,074	1,169	1,270	1,413	1,550
Selling, General & Admin Expense	697	764	853	964	1,039	868	950	1,027	1,139	1,251
Depreciation Expense	140	173	184	200	219	203	220	244	274	300
Total Other Income / (Expense), net	-151	-167	-153	-136	-130	-175	-154	-179	-125	-115
Interest Expense	165	180	165	147	167	186	165	177	144	138
Interest & Investment Income	8.70	9.80	8.00	8.70	6.70	2.90	3.40	2.90	3.20	3.00
Other Income / (Expense), net	5.50	2.90	4.10	2.20	31	8.40	7.50	-5.20	16	20
Income Tax Expense	142	164	146	119	116	75	102	100	132	150
Net Income / (Loss) Discontinued Operations	-0.90	0.00	-0.40	1.10	-0.60	91	114	15	-12	-2.80
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	87	85	105	95	111	141
Basic Earnings per Share	$2.02	$2.77	$2.88	$2.98	$3.65	$2.87	$4.15	$2.72	$3.51	$4.53
Weighted Average Basic Shares Outstanding	89.40M	89.10M	93.70M	97.90M	98M	98.60M	99M	99.20M	99.50M	99.90M
Diluted Earnings per Share	$1.91	$2.59	$2.84	$2.93	$3.61	$2.85	$4.11	$2.70	$3.47	$4.46
Weighted Average Diluted Shares Outstanding	101M	99.50M	99.30M	99.80M	99.40M	99.80M	100.20M	100.40M	101.30M	102.20M
Weighted Average Basic & Diluted Shares Outstanding	89.78M	89.05M	99.30M	98.10M	98.43M	99.27M	99.44M	99.73M	100.14M	100.71M
Cash Dividends to Common per Share	$0.88	$0.94	$0.98	$1.04	$1.10	$1.12	$1.12	$0.86	$0.60	$0.64

This table shows Encompass Health's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	45	89	88	91	85	88	113	114	108	121
Consolidated Net Income / (Loss)	45	139	113	117	113	119	139	147	147	164
Net Income / (Loss) Continuing Operations	86	119	114	118	115	128	140	148	148	164
Total Pre-Tax Income	107	151	146	151	145	165	178	186	184	201
Total Operating Income	148	180	179	184	179	190	208	216	209	232
Total Gross Profit	472	510	518	537	534	557	590	587	605	634
Total Revenue	1,090	1,137	1,160	1,187	1,207	1,247	1,316	1,301	1,351	1,405
Operating Revenue	1,090	1,137	1,160	1,187	1,207	1,247	1,316	1,301	1,351	1,405
Total Cost of Revenue	618	628	643	651	673	690	726	715	747	772
Operating Cost of Revenue	618	628	643	651	673	690	726	715	747	772
Total Operating Expenses	323	330	339	353	355	367	383	371	395	401
Selling, General & Admin Expense	261	267	275	280	287	297	313	298	317	323
Depreciation Expense	62	63	64	73	67	70	70	73	78	78
Total Other Income / (Expense), net	-41	-29	-32	-33	-34	-25	-29	-30	-25	-31
Interest Expense	38	38	36	36	36	35	35	34	35	33
Interest & Investment Income	0.70	0.30	0.40	0.90	1.00	0.90	0.70	1.40	0.70	0.20
Other Income / (Expense), net	-3.60	8.40	3.60	2.70	0.50	8.90	5.40	3.30	9.30	2.10
Income Tax Expense	22	32	32	33	30	37	38	38	36	38
Net Income / (Loss) Discontinued Operations	-19	-1.50	-1.00	-1.20	-1.30	-8.50	-1.30	-1.20	-0.70	0.40
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	26	26	28	32	26	32	39	43
Basic Earnings per Share	$0.45	$0.90	$0.88	$0.91	$0.85	$0.88	$1.12	$1.13	$1.08	$1.20
Weighted Average Basic Shares Outstanding	99.20M	99.20M	99.40M	99.50M	99.50M	99.50M	99.80M	99.90M	99.90M	99.90M
Diluted Earnings per Share	$0.45	$0.90	$0.87	$0.90	$0.84	$0.88	$1.10	$1.12	$1.06	$1.18
Weighted Average Diluted Shares Outstanding	100.50M	100.40M	100.90M	101.10M	101.40M	101.30M	102.20M	102M	102.10M	102.20M
Weighted Average Basic & Diluted Shares Outstanding	99.79M	99.73M	100.24M	100.23M	100.24M	100.14M	100.69M	100.63M	100.75M	100.71M

This table details how cash moves in and out of Encompass Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-5.10	-6.10	15	17	26	151	-191	-67	51	19
Net Cash From Operating Activities	502	640	658	762	635	705	716	706	851	1,003
Net Cash From Continuing Operating Activities	502	640	658	762	640	705	716	706	851	1,003
Net Income / (Loss) Continuing Operations	254	318	351	374	446	278	403	351	475	599
Consolidated Net Income / (Loss)	253	318	350	375	446	369	517	366	463	597
Net Income / (Loss) Discontinued Operations	-0.90	0.00	0.40	1.10	-0.60	91	114	15	-12	-2.80
Depreciation Expense	140	173	184	200	219	203	220	244	274	300
Amortization Expense	14	14	8.70	4.00	4.50	7.20	7.80	9.70	9.50	9.70
Non-Cash Adjustments To Reconcile Net Income	97	33	62	148	110	74	178	104	38	62
Changes in Operating Assets and Liabilities, net	-2.80	103	53	37	-140	143	-93	-2.50	54	33
Net Cash From Investing Activities	-1,130	-230	-283	-425	-657	-408	-666	-627	-603	-653
Net Cash From Continuing Investing Activities	-1,130	-230	-283	-425	-657	-405	-547	-624	-603	-653
Purchase of Property, Plant & Equipment	-157	-203	-245	-271	-385	-401	-546	-584	-583	-643
Purchase of Investments	-7.10	-1.30	-8.50	-13	-33	-8.70	-9.00	-35	-23	-23
Sale and/or Maturity of Investments	13	0.10	4.20	12	18	13	-	0.00	7.40	19
Other Investing Activities, net	1.60	-1.70	8.80	-2.70	-6.50	-3.80	7.60	-4.20	-4.10	-7.20
Net Cash From Discontinued Investing Activities	0.50	0.10	-	-	-	-3.00	-119	-3.50	0.00	0.00
Net Cash From Financing Activities	623	-416	-360	-321	48	-146	-240	-146	-197	-331
Net Cash From Continuing Financing Activities	623	-416	-360	-321	48	-134	-230	-661	-197	-331
Repayment of Debt	-1,376	-529	-480	-429	-1,169	-1,126	-315	-755	-162	-335
Repurchase of Common Equity	-45	-66	-38	0.00	-46	-6.10	-	0.00	0.00	-31
Payment of Dividends	-132	-149	-143	-241	-351	-345	-213	-196	-175	-188
Issuance of Debt	2,190	335	274	344	1,635	1,323	300	252	80	95
Issuance of Common Equity	3.00	3.50	21	13	16	35	57	64	68	140
Other Financing Activities, net	-17	-12	6.80	-8.30	-36	-15	-59	-27	-8.20	-12
Net Cash From Discontinued Financing Activities	-	-	-	-	-	-12	-10	515	0.00	0.00
Cash Interest Paid	121	164	151	150	156	168	168	178	148	147
Cash Income Taxes Paid	17	33	96	115	104	34	131	51	109	165

This table details how cash moves in and out of Encompass Health's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-153	-51	66	35	-13	-37	69	9.40	17	-76
Net Cash From Operating Activities	70	172	228	207	215	201	239	217	268	279
Net Cash From Continuing Operating Activities	146	172	228	207	215	201	239	217	268	279
Net Income / (Loss) Continuing Operations	86	119	114	118	115	128	140	148	148	164
Consolidated Net Income / (Loss)	67	118	113	117	113	119	139	147	147	164
Net Income / (Loss) Discontinued Operations	-19	-1.50	-1.00	-1.20	-1.30	-8.50	-1.30	-1.20	-0.70	0.40
Depreciation Expense	62	63	64	73	67	70	70	73	78	78
Non-Cash Adjustments To Reconcile Net Income	70	-1.50	7.80	16	19	-4.40	24	11	11	16
Changes in Operating Assets and Liabilities, net	-71	-18	42	-0.20	14	-1.80	4.90	-14	30	11
Net Cash From Investing Activities	-174	-206	-104	-129	-162	-208	-130	-158	-162	-204
Net Cash From Continuing Investing Activities	-174	-207	-104	-129	-162	-208	-130	-158	-162	-204
Purchase of Property, Plant & Equipment	-149	-209	-100	-122	-150	-212	-139	-157	-148	-199
Purchase of Investments	-	-10	-	-	-	-1.90	-	-	-	-2.50
Sale and/or Maturity of Investments	-	-	0.20	0.80	6.00	0.40	16	1.00	0.90	1.00
Other Investing Activities, net	0.20	13	-4.40	-7.40	2.60	5.10	-6.30	-2.50	5.10	-3.50
Net Cash From Financing Activities	-49	-17	-58	-44	-66	-30	-41	-50	-90	-151
Net Cash From Continuing Financing Activities	4.70	-16	-58	-44	-66	-30	-41	-50	-90	-151
Repayment of Debt	-24	-34	-50	-80	9.60	-42	-56	-5.00	-140	-134
Repurchase of Common Equity	-	-	-	-	-	-	-	-	-6.80	-7.50
Payment of Dividends	-50	-43	-47	-43	-48	-38	-41	-43	-48	-57
Issuance of Debt	50	72	30	50	-	-	50	-	15	30
Issuance of Common Equity	20	9.00	17	29	8.40	14	18	15	106	0.70
Other Financing Activities, net	9.40	-19	-7.70	-	-36	36	-12	-	-16	16

This table presents Encompass Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	4,606	4,682	2,089	5,175	6,081	6,446	6,865	5,637	6,102	6,535
Total Current Assets	599	655	117	662	756	949	921	717	842	887
Cash & Equivalents	62	41	54	69	95	224	49	22	69	85
Restricted Cash	46	61	62	-	57	65	63	32	35	38
Accounts Receivable	411	444	-	468	506	573	516	537	612	599
Prepaid Expenses	81	109	-	66	98	86	115	35	35	42
Other Current Assets	-	-	-	59	-	-	-	92	92	123
Plant, Property, & Equipment, net	1,310	1,392	0.00	1,635	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	2,697	2,636	1,973	2,878	5,325	5,497	5,944	4,919	5,261	5,648
Goodwill	1,890	1,927	1,973	2,101	2,305	2,319	1,237	1,263	1,281	1,284
Intangible Assets	419	411	-	443	476	431	158	282	278	298
Other Noncurrent Operating Assets	197	221	-	291	2,541	2,747	3,005	3,374	3,701	4,066
Total Liabilities & Shareholders' Equity	4,606	4,682	0.00	5,175	6,081	6,446	6,865	5,637	6,102	6,535
Total Liabilities	3,706	3,615	0.00	3,356	4,148	4,444	4,466	3,775	3,805	3,686
Total Current Liabilities	426	476	0.00	673	721	717	749	576	656	841
Short-Term Debt	37	37	-	36	39	38	38	25	25	139
Accounts Payable	62	68	-	90	95	115	134	133	170	171
Current Employee Benefit Liabilities	126	147	-	188	211	254	199	168	208	228
Other Current Liabilities	172	197	-	334	344	263	201	207	212	265
Other Current Nonoperating Liabilities	30	26	-	24	32	47	177	43	43	39
Total Noncurrent Liabilities	3,279	3,139	0.00	2,684	3,427	3,727	3,717	3,199	3,149	2,845
Long-Term Debt	3,135	2,979	-	2,479	3,023	3,251	3,241	2,742	2,688	2,359
Asset Retirement Reserve & Litigation Obligation	102	110	-	120	117	121	124	129	132	139
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	0.00	52	23	83	87	105
Other Noncurrent Operating Liabilities	43	50	-	86	287	303	229	245	242	242
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	121	138	-	262	240	32	42	36	42	57
Total Equity & Noncontrolling Interests	779	929	0.00	1,557	1,693	1,970	2,357	1,826	2,255	2,793
Total Preferred & Common Equity	611	736	0.00	1,277	1,352	1,588	1,911	1,310	1,648	2,067
Total Common Equity	611	736	0.00	1,277	1,352	1,588	1,911	1,310	1,648	2,067
Common Stock	2,836	2,800	-	2,590	2,371	2,328	2,291	1,731	1,788	1,848
Retained Earnings	-1,696	-1,448	-	-885	-527	-242	142	116	407	797
Treasury Stock	-527	-615	-	-428	-492	-497	-521	-537	-547	-578
Noncontrolling Interest	168	193	-	280	341	382	446	516	608	726

This table presents Encompass Health's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	5,476	5,747	5,861	5,964	6,231	6,389	6,458
Total Current Assets	734	762	824	814	930	938	934
Cash & Equivalents	60	85	118	100	134	154	148
Restricted Cash	44	34	37	42	38	28	51
Accounts Receivable	500	515	532	536	619	590	576
Other Current Assets	130	128	138	137	138	166	159
Plant, Property, & Equipment, net	2,807	2,988	0.00	3,186	3,370	3,439	3,524
Total Noncurrent Assets	1,935	1,997	5,037	1,964	1,931	2,012	2,001
Goodwill	1,247	1,271	1,271	1,281	1,281	1,284	1,284
Intangible Assets	285	287	278	276	272	303	296
Other Noncurrent Operating Assets	402	439	3,488	407	378	425	421
Total Liabilities & Shareholders' Equity	5,476	5,747	5,861	5,964	6,231	6,389	6,458
Total Liabilities	3,728	3,784	3,804	3,775	3,828	3,859	3,733
Total Current Liabilities	605	592	655	639	680	695	897
Short-Term Debt	26	26	23	24	26	33	233
Accounts Payable	134	141	156	165	166	164	170
Other Current Liabilities	444	393	442	450	489	498	494
Total Noncurrent Liabilities	3,123	3,192	3,149	3,136	3,148	3,164	2,835
Long-Term Debt	2,719	2,723	2,698	2,693	2,683	2,684	2,345
Noncurrent Deferred & Payable Income Tax Liabilities	47	87	83	80	94	91	97
Other Noncurrent Operating Liabilities	357	383	368	363	372	389	394
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	38	38	39	42	41	49	57
Total Equity & Noncontrolling Interests	1,710	1,926	2,018	2,148	2,362	2,481	2,669
Total Preferred & Common Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	1,710	1,926	2,018	2,148	2,362	2,481	2,669

This table displays calculated financial ratios and metrics derived from Encompass Health's official financial filings.

Metric	2015	2016	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	31.46%	15.17%	9.28%	7.66%	-22.56%	12.58%	8.31%	10.41%	11.91%
EBITDA Growth	14.09%	18.68%	-1.24%	13.25%	-21.14%	19.85%	-1.79%	17.37%	15.81%
EBIT Growth	10.75%	18.02%	-3.32%	14.43%	-25.86%	24.42%	-6.28%	19.60%	18.34%
NOPAT Growth	5.08%	22.13%	4.18%	15.06%	-24.35%	26.55%	-6.85%	16.77%	20.75%
Net Income Growth	-17.52%	35.23%	7.82%	52.51%	-17.27%	40.24%	-29.25%	26.54%	28.86%
EPS Growth	-16.59%	35.60%	3.17%	23.21%	-17.27%	40.24%	-34.31%	28.52%	28.53%
Operating Cash Flow Growth	12.83%	27.53%	15.81%	-16.67%	10.92%	1.58%	-1.40%	20.54%	17.87%
Free Cash Flow Firm Growth	-70.65%	150.18%	-173.70%	97.96%	749.69%	497.54%	-100.47%	3,648.60%	55.41%
Invested Capital Growth	41.76%	0.34%	117.39%	13.69%	3.54%	-18.36%	12.06%	7.14%	6.35%
Revenue Q/Q Growth	9.18%	0.17%	2.08%	1.96%	-22.71%	9.54%	17.62%	2.33%	3.03%
EBITDA Q/Q Growth	11.06%	2.90%	-5.61%	7.52%	-13.60%	3.65%	18.56%	2.69%	4.66%
EBIT Q/Q Growth	8.25%	1.15%	-8.67%	8.43%	-14.19%	-1.58%	24.06%	1.45%	4.19%
NOPAT Q/Q Growth	3.04%	3.98%	-10.48%	10.99%	-14.19%	0.21%	20.70%	0.92%	6.45%
Net Income Q/Q Growth	-8.27%	6.68%	-9.22%	39.66%	-24.66%	18.76%	6.83%	-4.14%	8.18%
EPS Q/Q Growth	3.24%	7.92%	-14.33%	-12.38%	-24.66%	18.76%	-1.82%	-2.53%	5.44%
Operating Cash Flow Q/Q Growth	14.51%	1.11%	3.67%	6.22%	10.01%	-17.88%	7.36%	3.50%	8.41%
Free Cash Flow Firm Q/Q Growth	-61.66%	166.98%	-585.24%	88.73%	-60.62%	651.35%	-100.51%	26.37%	21.69%
Invested Capital Q/Q Growth	36.46%	1.27%	-0.37%	-4.99%	0.99%	-22.69%	5.22%	3.85%	3.10%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	45.68%	45.48%	44.97%	42.34%	44.90%	45.55%	43.71%	44.67%	44.94%
EBITDA Margin	22.33%	23.01%	19.53%	20.55%	20.92%	22.27%	20.20%	21.47%	22.22%
Operating Margin	17.28%	17.81%	14.72%	15.04%	14.79%	16.42%	14.49%	15.24%	16.09%
EBIT Margin	17.46%	17.89%	14.77%	15.70%	15.03%	16.61%	14.37%	15.57%	16.46%
Profit (Net Income) Margin	5.79%	6.80%	6.83%	9.68%	10.34%	12.88%	8.41%	9.64%	11.10%
Tax Burden Percent	46.28%	51.37%	59.27%	79.28%	104.51%	102.42%	81.17%	76.25%	79.59%
Interest Burden Percent	71.64%	73.96%	78.06%	77.77%	65.84%	75.72%	72.13%	81.23%	84.74%
Effective Tax Rate	35.87%	34.00%	24.11%	20.61%	21.17%	20.18%	22.21%	21.77%	20.04%
Return on Invested Capital (ROIC)	10.29%	10.70%	15.26%	12.00%	8.38%	11.48%	11.22%	11.97%	13.54%
ROIC Less NNEP Spread (ROIC-NNEP)	3.74%	4.72%	6.91%	8.16%	6.81%	11.10%	5.67%	7.92%	9.80%
Return on Net Nonoperating Assets (RNNOA)	11.27%	14.47%	16.88%	11.77%	10.37%	12.02%	5.95%	10.30%	9.64%
Return on Equity (ROE)	21.57%	25.17%	32.14%	23.77%	18.75%	23.50%	17.17%	22.26%	23.19%
Cash Return on Invested Capital (CROIC)	-24.25%	10.36%	-58.71%	-0.82%	4.90%	31.70%	-0.16%	5.07%	7.38%
Operating Return on Assets (OROA)	13.81%	14.03%	17.39%	12.85%	8.56%	10.02%	10.00%	12.74%	14.00%
Return on Assets (ROA)	4.58%	5.33%	8.05%	7.92%	5.89%	7.77%	5.85%	7.89%	9.44%
Return on Common Equity (ROCE)	13.78%	17.24%	22.56%	16.66%	14.01%	18.69%	12.98%	15.83%	16.73%
Return on Equity Simple (ROE_SIMPLE)	29.95%	33.65%	22.90%	32.97%	23.22%	27.06%	27.92%	28.10%	28.86%
Net Operating Profit after Tax (NOPAT)	351	428	478	550	416	526	490	572	691
NOPAT Margin	11.08%	11.75%	11.17%	11.94%	11.66%	13.11%	11.27%	11.92%	12.87%
Net Nonoperating Expense Percent (NNEP)	6.55%	5.99%	8.35%	3.84%	1.57%	0.38%	5.55%	4.05%	3.74%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	10.67%	11.52%	13.07%
Cost of Revenue to Revenue	54.32%	54.52%	55.03%	57.66%	55.10%	54.45%	56.29%	55.33%	55.06%
SG&A Expenses to Revenue	22.04%	20.97%	22.54%	22.55%	24.33%	23.65%	23.61%	23.73%	23.28%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	28.40%	27.67%	30.25%	27.30%	30.10%	29.12%	29.21%	29.43%	28.85%
Earnings before Interest and Taxes (EBIT)	552	652	632	723	536	667	625	748	885
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	706	838	836	946	746	894	878	1,031	1,194
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.53	4.48	4.42	4.75	4.96	3.30	4.48	4.03	4.49
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	12.23	0.00	75.45	19.14
Price to Revenue (P/Rev)	0.88	0.91	1.32	1.40	2.21	1.57	1.35	1.38	1.73
Price to Earnings (P/E)	15.26	13.33	15.04	17.92	27.70	15.31	21.66	18.86	20.38
Dividend Yield	2.91%	2.56%	1.82%	1.69%	1.41%	1.77%	1.37%	0.91%	0.67%
Earnings Yield	6.55%	7.50%	6.65%	5.58%	3.61%	6.53%	4.62%	5.30%	4.91%
Enterprise Value to Invested Capital (EV/IC)	1.53	1.63	2.01	2.03	2.24	2.42	1.98	2.00	2.36
Enterprise Value to Revenue (EV/Rev)	1.94	1.80	2.02	2.15	3.16	2.48	2.10	2.06	2.32
Enterprise Value to EBITDA (EV/EBITDA)	8.67	7.81	10.33	10.48	15.12	11.14	10.40	9.60	10.42
Enterprise Value to EBIT (EV/EBIT)	11.09	10.05	13.66	13.72	21.05	14.94	14.61	13.24	14.07
Enterprise Value to NOPAT (EV/NOPAT)	17.46	15.29	18.07	18.04	27.13	18.93	18.63	17.29	18.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.20	10.23	11.32	15.61	16.01	13.92	12.94	11.63	12.41
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	15.79	0.00	0.00	46.40	6.86	0.00	40.80	33.01
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	3.52	2.83	1.38	1.58	1.64	1.37	1.49	1.18	0.88
Long-Term Debt to Equity	3.48	2.79	1.36	1.56	1.62	1.35	1.47	1.17	0.83
Financial Leverage	3.01	3.07	2.44	1.44	1.52	1.08	1.05	1.30	0.98
Leverage Ratio	4.71	4.72	3.99	3.00	3.18	3.02	2.93	2.82	2.46
Compound Leverage Factor	3.37	3.49	3.12	2.33	2.10	2.29	2.12	2.29	2.08
Debt to Total Capital	77.89%	73.87%	58.03%	61.31%	62.17%	57.74%	59.78%	54.15%	46.71%
Short-Term Debt to Total Capital	0.90%	0.91%	0.83%	0.79%	0.72%	0.67%	0.54%	0.50%	2.59%
Long-Term Debt to Total Capital	76.98%	72.96%	57.20%	60.52%	61.44%	57.08%	59.23%	53.65%	44.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.10%	8.11%	12.51%	11.62%	7.82%	8.59%	11.92%	12.97%	14.63%
Common Equity to Total Capital	15.02%	18.02%	29.46%	27.07%	30.02%	33.66%	28.31%	32.89%	38.66%
Debt to EBITDA	4.49	3.60	3.01	3.24	4.41	3.67	3.15	2.63	2.09
Net Debt to EBITDA	4.34	3.48	2.93	3.08	4.02	3.54	3.09	2.53	1.99
Long-Term Debt to EBITDA	4.44	3.55	2.97	3.20	4.36	3.62	3.12	2.61	1.98
Debt to NOPAT	9.05	7.04	5.26	5.57	7.91	6.23	5.64	4.74	3.61
Net Debt to NOPAT	8.74	6.81	5.12	5.29	7.21	6.02	5.54	4.56	3.44
Long-Term Debt to NOPAT	8.94	6.96	5.19	5.50	7.82	6.16	5.59	4.70	3.41
Altman Z-Score	1.06	1.40	2.00	1.97	1.88	1.81	2.13	2.37	2.96
Noncontrolling Interest Sharing Ratio	36.12%	31.52%	29.80%	29.92%	25.27%	20.48%	24.40%	28.88%	27.82%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	1.40	1.38	0.98	1.05	1.32	1.23	1.25	1.28	1.05
Quick Ratio	1.11	1.02	0.80	0.83	1.11	0.75	0.97	1.04	0.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-826	414	-1,838	-37	243	1,453	-6.84	243	377
Operating Cash Flow to CapEx	329.18%	357.65%	281.85%	164.84%	175.69%	131.17%	120.84%	145.91%	156.08%
Free Cash Flow to Firm to Interest Expense	-5.00	2.31	-12.48	-0.22	1.31	8.79	-0.04	1.69	2.73
Operating Cash Flow to Interest Expense	3.04	3.57	5.18	3.80	3.79	4.33	3.99	5.93	7.27
Operating Cash Flow Less CapEx to Interest Expense	2.11	2.57	3.34	1.49	1.63	1.03	0.69	1.87	2.61
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.79	0.78	1.18	0.82	0.57	0.60	0.70	0.82	0.85
Accounts Receivable Turnover	8.62	8.53	0.00	9.46	6.61	7.38	8.26	8.36	8.88
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	2.72	2.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	29.88	30.58	0.00	28.77	18.75	17.56	18.34	17.54	17.35
Days Sales Outstanding (DSO)	42.33	42.80	0.00	38.59	55.21	49.48	44.18	43.65	41.11
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	12.22	11.94	0.00	12.69	19.46	20.79	19.90	20.81	21.04
Cash Conversion Cycle (CCC)	30.12	30.86	0.00	25.90	35.75	28.70	24.28	22.84	20.07
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	3,994	4,008	4,288	4,876	5,048	4,121	4,618	4,948	5,263
Invested Capital Turnover	0.93	0.91	1.37	1.01	0.72	0.88	1.00	1.00	1.05
Increase / (Decrease) in Invested Capital	1,177	14	2,316	587	173	-927	497	330	314
Enterprise Value (EV)	6,123	6,546	8,632	9,919	11,284	9,963	9,134	9,898	12,444
Market Capitalization	2,770	3,300	5,645	6,429	7,871	6,309	5,869	6,640	9,287
Book Value per Share	$6.69	$8.20	$12.91	$13.71	$15.97	$19.21	$13.13	$16.44	$20.52
Tangible Book Value per Share	($18.57)	($17.85)	($12.81)	($14.50)	($11.69)	$5.19	($2.36)	$0.88	$4.82
Total Capital	4,072	4,083	4,333	4,995	5,291	5,678	4,629	5,010	5,347
Total Debt	3,172	3,016	2,514	3,063	3,289	3,278	2,767	2,713	2,498
Total Long-Term Debt	3,135	2,979	2,479	3,023	3,251	3,241	2,742	2,688	2,359
Net Debt	3,064	2,915	2,445	2,910	3,000	3,166	2,714	2,608	2,375
Capital Expenditures (CapEx)	153	179	271	385	401	546	584	583	643
Debt-free, Cash-free Net Working Capital (DFCFNWC)	102	115	-44	-78	-20	99	113	106	61
Debt-free Net Working Capital (DFNWC)	209	216	25	74	270	210	167	210	185
Net Working Capital (NWC)	172	179	-10	35	231	173	141	185	46
Net Nonoperating Expense (NNE)	168	181	186	104	47	9.14	124	109	95
Net Nonoperating Obligations (NNO)	3,094	2,941	2,470	2,943	3,047	1,722	2,756	2,651	2,413
Total Depreciation and Amortization (D&A)	154	186	204	223	210	227	253	283	309
Debt-free, Cash-free Net Working Capital to Revenue	3.21%	3.15%	-1.02%	-1.70%	-0.56%	2.45%	2.60%	2.21%	1.14%
Debt-free Net Working Capital to Revenue	6.61%	5.93%	0.59%	1.61%	7.56%	5.24%	3.83%	4.38%	3.43%
Net Working Capital to Revenue	5.45%	4.91%	-0.24%	0.76%	6.49%	4.30%	3.25%	3.86%	0.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.61	$2.21	$2.37	$2.91	$2.28	$3.30	$2.72	$3.51	$4.53
Adjusted Weighted Average Basic Shares Outstanding	112.29M	111.91M	122.96M	123.09M	123.84M	124.35M	99.20M	99.50M	99.90M
Adjusted Diluted Earnings per Share	$1.52	$2.06	$2.33	$2.87	$2.27	$3.27	$2.70	$3.47	$4.46
Adjusted Weighted Average Diluted Shares Outstanding	126.86M	124.97M	125.35M	124.85M	125.35M	125.85M	100.40M	101.30M	102.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	112.76M	111.85M	124.02M	123.63M	124.68M	124.90M	99.73M	100.14M	100.71M
Normalized Net Operating Profit after Tax (NOPAT)	355	428	517	550	418	526	490	572	691
Normalized NOPAT Margin	11.24%	11.75%	12.09%	11.94%	11.72%	13.11%	11.27%	11.92%	12.87%
Pre Tax Income Margin	12.51%	13.23%	11.53%	12.21%	9.90%	12.58%	10.37%	12.65%	13.95%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.34	3.63	4.29	4.32	2.88	4.03	3.53	5.21	6.41
NOPAT to Interest Expense	2.12	2.39	3.24	3.28	2.24	3.18	2.77	3.99	5.01
EBIT Less CapEx to Interest Expense	2.42	2.63	2.45	2.02	0.73	0.73	0.23	1.15	1.75
NOPAT Less CapEx to Interest Expense	1.20	1.39	1.41	0.98	0.08	-0.12	-0.53	-0.07	0.35
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	71.87%	60.06%	82.55%	78.82%	93.55%	41.24%	53.46%	37.82%	31.48%
Augmented Payout Ratio	96.61%	86.55%	82.55%	89.12%	95.20%	41.24%	53.46%	37.82%	36.69%

This table displays calculated financial ratios and metrics derived from Encompass Health's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.79%	134.01%	9.54%	11.73%	10.78%	9.63%	13.41%	9.61%	11.94%	12.69%
EBITDA Growth	1.27%	103.40%	19.06%	27.31%	19.48%	6.96%	15.08%	12.58%	20.06%	16.18%
EBIT Growth	-13.45%	181.17%	22.28%	30.40%	24.24%	5.69%	16.85%	17.31%	21.40%	17.91%
NOPAT Growth	-10.91%	129.16%	16.49%	33.05%	20.01%	3.76%	16.70%	18.89%	18.49%	28.49%
Net Income Growth	-64.17%	20.22%	2.91%	64.38%	149.78%	-14.38%	22.51%	25.00%	29.72%	37.87%
EPS Growth	-55.00%	-3.23%	0.00%	83.67%	86.67%	-2.22%	26.44%	24.44%	26.19%	34.09%
Operating Cash Flow Growth	-60.53%	39.10%	4.11%	-15.49%	206.99%	16.72%	4.78%	5.18%	24.44%	38.71%
Free Cash Flow Firm Growth	632.32%	-135.94%	390.68%	599.21%	-122.03%	48.54%	-115.99%	-124.75%	26.54%	31.44%
Invested Capital Growth	-17.66%	12.06%	-18.00%	-16.99%	8.55%	7.14%	7.55%	9.54%	7.13%	6.35%
Revenue Q/Q Growth	2.54%	4.39%	2.03%	2.30%	1.67%	3.31%	5.55%	-1.12%	3.83%	4.00%
EBITDA Q/Q Growth	1.62%	21.51%	-2.11%	5.32%	-4.63%	8.78%	5.32%	3.04%	1.71%	5.26%
EBIT Q/Q Growth	1.19%	29.90%	-3.14%	2.41%	-3.59%	10.51%	7.09%	2.82%	-0.23%	7.33%
NOPAT Q/Q Growth	9.25%	19.84%	-1.47%	3.13%	-1.45%	3.61%	10.83%	5.06%	-1.79%	12.36%
Net Income Q/Q Growth	-36.33%	206.39%	-18.55%	3.44%	-3.24%	5.03%	-5.71%	5.55%	0.41%	11.62%
EPS Q/Q Growth	-8.16%	100.00%	-3.33%	3.45%	-6.67%	4.76%	25.00%	1.82%	-5.36%	11.32%
Operating Cash Flow Q/Q Growth	-71.34%	145.65%	32.35%	-9.30%	4.11%	-6.60%	18.81%	-8.96%	23.18%	4.11%
Free Cash Flow Firm Q/Q Growth	585.04%	-133.54%	422.95%	-4.98%	-121.40%	21.65%	-30.86%	-47.04%	36.47%	26.88%
Invested Capital Q/Q Growth	-21.20%	5.22%	-0.56%	0.68%	3.05%	3.85%	0.68%	2.54%	0.78%	3.10%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.28%	44.83%	44.61%	45.20%	44.25%	44.63%	44.86%	45.07%	44.74%	45.09%
EBITDA Margin	18.99%	22.11%	21.21%	21.83%	20.48%	21.57%	21.52%	22.43%	21.97%	22.23%
Operating Margin	13.62%	15.80%	15.39%	15.49%	14.86%	15.23%	15.77%	16.57%	15.48%	16.53%
EBIT Margin	13.29%	16.54%	15.70%	15.72%	14.91%	15.94%	16.18%	16.82%	16.17%	16.68%
Profit (Net Income) Margin	4.17%	12.23%	9.76%	9.87%	9.40%	9.55%	10.55%	11.26%	10.89%	11.69%
Tax Burden Percent	42.31%	92.18%	77.50%	77.51%	78.21%	72.27%	77.80%	78.76%	80.03%	81.53%
Interest Burden Percent	74.10%	80.22%	80.24%	81.03%	80.60%	82.90%	83.80%	84.97%	84.16%	85.92%
Effective Tax Rate	20.32%	21.14%	21.82%	21.69%	20.90%	22.57%	21.47%	20.59%	19.59%	18.67%
Return on Invested Capital (ROIC)	8.26%	12.40%	10.51%	10.89%	12.05%	11.84%	12.88%	13.77%	13.15%	14.15%
ROIC Less NNEP Spread (ROIC-NNEP)	5.69%	12.28%	9.59%	9.93%	10.96%	10.80%	11.94%	12.81%	12.30%	13.18%
Return on Net Nonoperating Assets (RNNOA)	8.00%	12.91%	12.35%	12.07%	14.52%	14.05%	14.13%	14.24%	12.40%	12.97%
Return on Equity (ROE)	16.25%	25.31%	22.86%	22.95%	26.58%	25.88%	27.01%	28.01%	25.56%	27.12%
Cash Return on Invested Capital (CROIC)	27.73%	-0.16%	29.79%	29.24%	4.19%	5.07%	5.23%	3.76%	6.28%	7.38%
Operating Return on Assets (OROA)	8.06%	11.51%	11.01%	11.11%	12.23%	13.04%	13.39%	13.93%	13.57%	14.19%
Return on Assets (ROA)	2.53%	8.51%	6.85%	6.98%	7.71%	7.81%	8.73%	9.32%	9.14%	9.94%
Return on Common Equity (ROCE)	0.00%	19.14%	0.00%	0.00%	0.00%	18.41%	0.00%	0.00%	0.00%	19.57%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	118	142	140	144	142	147	163	171	168	189
NOPAT Margin	10.85%	12.46%	12.03%	12.13%	11.76%	11.79%	12.38%	13.16%	12.45%	13.45%
Net Nonoperating Expense Percent (NNEP)	2.57%	0.12%	0.92%	0.96%	1.09%	1.03%	0.94%	0.97%	0.85%	0.98%
Return On Investment Capital (ROIC_SIMPLE)	-	3.09%	-	-	-	2.96%	-	-	-	3.57%
Cost of Revenue to Revenue	56.72%	55.17%	55.39%	54.80%	55.75%	55.37%	55.14%	54.93%	55.26%	54.91%
SG&A Expenses to Revenue	23.96%	23.46%	23.71%	23.60%	23.81%	23.78%	23.75%	22.90%	23.46%	23.00%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	29.66%	29.02%	29.21%	29.71%	29.39%	29.40%	29.10%	28.50%	29.27%	28.56%
Earnings before Interest and Taxes (EBIT)	145	188	182	187	180	199	213	219	218	234
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	207	251	246	259	247	269	283	292	297	312
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	4.48	0.00	0.00	0.00	4.03	0.00	0.00	0.00	4.49
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	75.45	0.00	0.00	0.00	19.14
Price to Revenue (P/Rev)	1.20	1.35	1.20	1.47	1.42	1.38	1.67	1.70	1.86	1.73
Price to Earnings (P/E)	16.26	21.66	19.69	21.45	18.88	18.86	21.91	21.58	22.98	20.38
Dividend Yield	1.97%	1.37%	1.36%	1.31%	0.90%	0.91%	0.73%	0.70%	0.62%	0.67%
Earnings Yield	6.15%	4.62%	5.08%	4.66%	5.30%	5.30%	4.56%	4.63%	4.35%	4.91%
Enterprise Value to Invested Capital (EV/IC)	2.01	1.98	2.16	2.46	2.40	2.00	2.67	2.70	2.90	2.36
Enterprise Value to Revenue (EV/Rev)	2.39	2.10	2.23	2.48	2.44	2.06	2.66	2.70	2.84	2.32
Enterprise Value to EBITDA (EV/EBITDA)	11.92	10.40	10.94	11.78	11.40	9.60	12.46	12.54	12.98	10.42
Enterprise Value to EBIT (EV/EBIT)	17.53	14.61	15.09	16.18	15.53	13.24	16.95	16.89	17.45	14.07
Enterprise Value to NOPAT (EV/NOPAT)	21.74	18.63	19.47	20.90	20.18	17.29	22.14	21.97	22.81	18.00
Enterprise Value to Operating Cash Flow (EV/OCF)	13.43	12.94	13.89	16.78	13.92	11.63	15.31	15.69	16.01	12.41
Enterprise Value to Free Cash Flow (EV/FCFF)	6.55	0.00	6.54	7.62	59.62	40.80	52.92	75.23	47.81	33.01
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.57	1.49	1.40	1.32	1.24	1.18	1.13	1.07	0.95	0.88
Long-Term Debt to Equity	1.56	1.47	1.39	1.31	1.23	1.17	1.12	1.06	0.86	0.83
Financial Leverage	1.41	1.05	1.29	1.22	1.33	1.30	1.18	1.11	1.01	0.98
Leverage Ratio	3.02	2.93	2.85	2.81	2.91	2.82	2.74	2.67	2.53	2.46
Compound Leverage Factor	2.24	2.35	2.29	2.28	2.34	2.34	2.30	2.27	2.13	2.11
Debt to Total Capital	61.10%	59.78%	58.33%	56.94%	55.38%	54.15%	52.98%	51.78%	48.60%	46.71%
Short-Term Debt to Total Capital	0.58%	0.54%	0.55%	0.48%	0.49%	0.50%	0.50%	0.62%	4.39%	2.59%
Long-Term Debt to Total Capital	60.52%	59.23%	57.78%	56.47%	54.89%	53.65%	52.48%	51.16%	44.21%	44.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	38.90%	11.92%	41.67%	43.06%	44.62%	12.97%	47.02%	48.22%	51.40%	14.63%
Common Equity to Total Capital	0.00%	28.31%	0.00%	0.00%	0.00%	32.89%	0.00%	0.00%	0.00%	38.66%
Debt to EBITDA	3.71	3.15	3.03	2.82	2.71	2.63	2.56	2.49	2.26	2.09
Net Debt to EBITDA	3.57	3.09	2.90	2.66	2.57	2.53	2.40	2.32	2.09	1.99
Long-Term Debt to EBITDA	3.67	3.12	3.00	2.80	2.68	2.61	2.53	2.46	2.06	1.98
Debt to NOPAT	6.76	5.64	5.39	5.01	4.79	4.74	4.55	4.36	3.97	3.61
Net Debt to NOPAT	6.50	5.54	5.15	4.72	4.54	4.56	4.26	4.07	3.66	3.44
Long-Term Debt to NOPAT	6.69	5.59	5.34	4.96	4.75	4.70	4.50	4.31	3.61	3.41
Altman Z-Score	1.51	1.87	1.76	1.98	1.98	2.07	2.25	2.29	2.49	2.63
Noncontrolling Interest Sharing Ratio	100.00%	24.40%	100.00%	100.00%	100.00%	28.88%	100.00%	100.00%	100.00%	27.82%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.21	1.25	1.29	1.26	1.27	1.28	1.37	1.35	1.04	1.05
Quick Ratio	0.93	0.97	1.01	0.99	0.99	1.04	1.11	1.07	0.81	0.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,060	-355	1,148	1,091	-233	-183	-184	-270	-171	-125
Operating Cash Flow to CapEx	46.95%	82.31%	228.36%	169.57%	143.75%	94.95%	171.31%	138.56%	181.56%	140.31%
Free Cash Flow to Firm to Interest Expense	27.74	-9.48	31.53	30.04	-6.50	-5.24	-5.21	-7.87	-4.86	-3.78
Operating Cash Flow to Interest Expense	1.84	4.59	6.26	5.69	5.99	5.76	6.78	6.34	7.59	8.40
Operating Cash Flow Less CapEx to Interest Expense	-2.07	-0.99	3.52	2.34	1.82	-0.31	2.82	1.76	3.41	2.41
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.70	0.70	0.71	0.82	0.82	0.83	0.83	0.84	0.85
Accounts Receivable Turnover	6.50	8.26	7.43	7.68	9.06	8.36	8.74	9.04	9.38	8.88
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	1.57	0.00	1.57	0.00	1.56	0.00	1.55	0.00
Accounts Payable Turnover	14.25	18.34	17.25	17.26	17.32	17.54	17.83	17.52	17.14	17.35
Days Sales Outstanding (DSO)	56.17	44.18	49.13	47.52	40.30	43.65	41.74	40.38	38.93	41.11
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	25.62	19.90	21.15	21.14	21.07	20.81	20.47	20.83	21.29	21.04
Cash Conversion Cycle (CCC)	30.55	24.28	27.98	26.38	19.22	22.84	21.28	19.55	17.63	20.07
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,389	4,618	4,592	4,623	4,765	4,948	4,939	5,065	5,104	5,263
Invested Capital Turnover	0.76	1.00	0.87	0.90	1.03	1.00	1.04	1.05	1.06	1.05
Increase / (Decrease) in Invested Capital	-941	497	-1,008	-947	375	330	347	441	340	314
Enterprise Value (EV)	8,831	9,134	9,932	11,355	11,445	9,898	13,194	13,687	14,812	12,444
Market Capitalization	4,443	5,869	5,340	6,732	6,680	6,640	8,255	8,623	9,707	9,287
Book Value per Share	$0.00	$13.13	$0.00	$0.00	$0.00	$16.44	$0.00	$0.00	$0.00	$20.52
Tangible Book Value per Share	($15.36)	($2.36)	($15.62)	($15.45)	($15.54)	$0.88	($15.51)	($15.76)	($15.70)	$4.82
Total Capital	4,493	4,629	4,712	4,777	4,906	5,010	5,112	5,247	5,303	5,347
Total Debt	2,745	2,767	2,749	2,720	2,717	2,713	2,708	2,717	2,578	2,498
Total Long-Term Debt	2,719	2,742	2,723	2,698	2,693	2,688	2,683	2,684	2,345	2,359
Net Debt	2,641	2,714	2,629	2,566	2,575	2,608	2,536	2,535	2,379	2,375
Capital Expenditures (CapEx)	149	209	100	122	150	212	139	157	148	199
Debt-free, Cash-free Net Working Capital (DFCFNWC)	51	113	76	38	57	106	102	94	71	61
Debt-free Net Working Capital (DFNWC)	155	167	196	192	198	210	275	276	270	185
Net Working Capital (NWC)	129	141	170	169	175	185	250	244	37	46
Net Nonoperating Expense (NNE)	73	2.61	26	27	29	28	24	25	21	25
Net Nonoperating Obligations (NNO)	2,642	2,756	2,629	2,566	2,575	2,651	2,536	2,535	2,379	2,413
Total Depreciation and Amortization (D&A)	62	63	64	73	67	70	70	73	78	78
Debt-free, Cash-free Net Working Capital to Revenue	1.38%	2.60%	1.71%	0.83%	1.22%	2.21%	2.07%	1.85%	1.35%	1.14%
Debt-free Net Working Capital to Revenue	4.20%	3.83%	4.40%	4.19%	4.23%	4.38%	5.55%	5.44%	5.17%	3.43%
Net Working Capital to Revenue	3.49%	3.25%	3.81%	3.69%	3.72%	3.86%	5.03%	4.80%	0.70%	0.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.45	$0.90	$0.88	$0.91	$0.85	$0.88	$1.12	$1.13	$1.08	$1.20
Adjusted Weighted Average Basic Shares Outstanding	99.20M	99.20M	99.40M	99.50M	99.50M	99.50M	99.80M	99.90M	99.90M	99.90M
Adjusted Diluted Earnings per Share	$0.45	$0.90	$0.87	$0.90	$0.84	$0.88	$1.10	$1.12	$1.06	$1.18
Adjusted Weighted Average Diluted Shares Outstanding	100.50M	100.40M	100.90M	101.10M	101.40M	101.30M	102.20M	102M	102.10M	102.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.90	$0.00	$0.00	$0.00	$0.88	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	99.79M	99.73M	100.24M	100.23M	100.24M	100.14M	100.69M	100.63M	100.75M	100.71M
Normalized Net Operating Profit after Tax (NOPAT)	118	142	140	144	142	147	163	171	168	189
Normalized NOPAT Margin	10.85%	12.46%	12.03%	12.13%	11.76%	11.79%	12.38%	13.16%	12.45%	13.45%
Pre Tax Income Margin	9.85%	13.27%	12.60%	12.74%	12.01%	13.22%	13.56%	14.29%	13.60%	14.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.79	5.02	5.01	5.14	5.01	5.70	6.05	6.38	6.19	7.06
NOPAT to Interest Expense	3.10	3.78	3.84	3.97	3.95	4.21	4.63	4.99	4.76	5.69
EBIT Less CapEx to Interest Expense	-0.12	-0.56	2.26	1.78	0.84	-0.37	2.09	1.81	2.01	1.08
NOPAT Less CapEx to Interest Expense	-0.81	-1.80	1.09	0.61	-0.22	-1.85	0.67	0.42	0.58	-0.29
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	59.82%	53.46%	52.48%	44.17%	37.41%	37.82%	34.45%	32.54%	30.64%	31.48%
Augmented Payout Ratio	59.82%	53.46%	52.48%	44.17%	37.41%	37.82%	34.45%	32.54%	30.64%	36.69%

Frequently Asked Questions About Encompass Health's Financials

When does Encompass Health's fiscal year end?

According to the most recent income statement we have on file, Encompass Health's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Encompass Health's net income changed over the last 9 years?

Encompass Health's net income appears to be on an upward trend, with a most recent value of $596.60 million in 2024, rising from $183.10 million in 2015. The previous period was $463 million in 2023.

What is Encompass Health's operating income?

Encompass Health's total operating income in 2024 was $864.50 million, based on the following breakdown:

Total Gross Profit: $2.41 billion
Total Operating Expenses: $1.55 billion

How has Encompass Health revenue changed over the last 9 years?

Over the last 9 years, Encompass Health's total revenue changed from $3.16 billion in 2015 to $5.37 billion in 2024, a change of 69.9%.

How much debt does Encompass Health have?

Encompass Health's total liabilities were at $3.69 billion at the end of 2024, a 3.1% decrease from 2023, and a 0.5% decrease since 2015.

How much cash does Encompass Health have?

In the past 9 years, Encompass Health's cash and equivalents has ranged from $21.80 million in 2022 to $224 million in 2020, and is currently $85.40 million as of their latest financial filing in 2024.

How has Encompass Health's book value per share changed over the last 8 years?

Over the last 8 years, Encompass Health's book value per share changed from 6.69 in 2015 to 20.52 in 2024, a change of 206.8%.

Remove Ads

Related Companies

This page (NYSE:EHC) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Encompass Health (EHC) Financials

Frequently Asked Questions About Encompass Health's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Encompass Health (EHC) Financials

Annual Income Statements for Encompass Health

Quarterly Income Statements for Encompass Health

Annual Cash Flow Statements for Encompass Health

Quarterly Cash Flow Statements for Encompass Health

Annual Balance Sheets for Encompass Health

Quarterly Balance Sheets for Encompass Health

Annual Metrics and Ratios for Encompass Health

Quarterly Metrics and Ratios for Encompass Health

Frequently Asked Questions About Encompass Health's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools